Related Experiment Video
Updated: Feb 19, 2026
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
Recent Advancements in Organotin(IV) Complexes as Potential Anticancer Agents
1Department of Chemistry, Guru Jambheshwar University of Science & Technology, Hisar, Haryana-125001, India.
Abstract:
Cancer is a multistep disease incorporating physical, chemical, environmental, metabolic and genetic factors, which play direct or indirect role in the induction and deterioration of cancer. Many of the platinum based drugs were synthesized but due to their systemic toxicity, broad spectrum of action, intrinsic and acquired drug resistivity, it has become necessary to search for the effective anticancer drugs with superior efficiency. Among non-platinum metal compounds with antitumor activity, organotin complexes have proven effective management of toxicity, specific targeted drug uptake by the cancerous cell line and significant potential in the pharmaceutical chemistry. So this article provides a critical review from 2010 onwards of the anticancer activity of the organotin complexes reported by the authors worldwide and explores the landmarks for their future projection as novel anticancer chemotypes with high therapeutic indices.
Insights
Organotin complexes show promise as effective anticancer drugs, offering targeted delivery and reduced toxicity compared to traditional platinum-based treatments. This review highlights their potential as novel chemotypes for future cancer therapy.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Oncology
Background:
- Cancer is a complex, multistep disease influenced by various factors.
- Platinum-based drugs are common but face challenges like toxicity and drug resistance.
- Non-platinum metal compounds are being explored for improved anticancer therapies.
Purpose of the Study:
- To critically review the anticancer activity of organotin complexes reported globally since 2010.
- To explore the potential of organotin complexes as novel anticancer chemotypes.
- To identify future research directions for organotin-based cancer therapeutics.
Main Methods:
- Literature review of scientific articles published from 2010 onwards.
- Analysis of reported anticancer activities of various organotin complexes.
- Evaluation of toxicity profiles and drug uptake mechanisms.
Main Results:
- Organotin complexes demonstrate significant antitumor activity.
- These complexes show potential for targeted drug delivery to cancer cells.
- Organotin compounds exhibit a favorable toxicity profile compared to platinum drugs.
Conclusions:
- Organotin complexes represent a promising class of non-platinum anticancer agents.
- Their targeted uptake and manageable toxicity suggest a high therapeutic index.
- Further research into organotin complexes could lead to novel, effective cancer chemotherapeutics.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
01:27Tumor Immunotherapy